Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Cazzola, L. Calzetta, C. P. Page, F. Facciolo, A. Gavaldà, M. G. Matera (Rome, Naples, Italy; London, United Kingdom; Barcelona, Spain). Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle. Eur Respir J 2014; 44: Suppl. 58, 954

Member's Comments

No comment yet.

Related content which might interest you: Interaction between aclidinium bromide and formoterol fumarate in small human airways Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Interaction between RPL554 and glycopyrronium bromide in small human airways Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Long-lasting interaction study between RPL554 and glycopyrronium bromide on human isolated bronchi Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 The combination therapy with inhaled tiotropium bromide and indacaterol in COPD improves the peripheral airway function in static and dynamic status Source: International Congress 2014 – Asthma and COPD management Year: 2014 Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Once-daily QVA149 improves lung function and dyspnoea compared with tiotropium plus formoterol: The QUANTIFY study Source: International Congress 2014 – Asthma and COPD management Year: 2014 Interaction between tiotropium bromide and olodaterol in human bronchial smooth muscle Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Tiotropium respimat: Comparison of bronchodilator efficacy of 5 and 2.5 µg doses Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Combination study of tiotropium and olodaterol in human precision-cut lung slices Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Effectiveness of glycopyrronium bromide in the treatment of small airways dysfunction Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Role of budesonide, formoterol fumarate and aclidinium bromide in the inflammaging of airway epithelial cells Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Effects of combining tiotropium and salmeterol/fluticasone propionate on airway dimensions in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Pharmacologic bronchodilation response to salbutamol in COPD patients Source: International Congress 2014 – Predictors Year: 2014